These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

177 related articles for article (PubMed ID: 20448213)

  • 1. Human CD34+ cells in experimental myocardial infarction: long-term survival, sustained functional improvement, and mechanism of action.
    Wang J; Zhang S; Rabinovich B; Bidaut L; Soghomonyan S; Alauddin MM; Bankson JA; Shpall E; Willerson JT; Gelovani JG; Yeh ET
    Circ Res; 2010 Jun; 106(12):1904-11. PubMed ID: 20448213
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Targeting human CD34+ hematopoietic stem cells with anti-CD45 x anti-myosin light-chain bispecific antibody preserves cardiac function in myocardial infarction.
    Zhao TC; Tseng A; Yano N; Tseng Y; Davol PA; Lee RJ; Lum LG; Padbury JF
    J Appl Physiol (1985); 2008 Jun; 104(6):1793-800. PubMed ID: 18292296
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Combined cord blood stem cells and gene therapy enhances angiogenesis and improves cardiac performance in mouse after acute myocardial infarction.
    Chen HK; Hung HF; Shyu KG; Wang BW; Sheu JR; Liang YJ; Chang CC; Kuan P
    Eur J Clin Invest; 2005 Nov; 35(11):677-86. PubMed ID: 16269017
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cardioprotective Potential of Human Endothelial-Colony Forming Cells from Diabetic and Nondiabetic Donors.
    Deutsch MA; Brunner S; Grabmaier U; David R; Ott I; Huber BC
    Cells; 2020 Mar; 9(3):. PubMed ID: 32131432
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparing the effects of MSCs and CD34+ cell therapy in a rat model of myocardial infarction.
    Shalaby SM; El-Shal AS; Zidan HE; Mazen NF; Abd El-Haleem MR; Abd El Motteleb DM
    IUBMB Life; 2016 May; 68(5):343-54. PubMed ID: 26949188
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Parathyroid hormone treatment after myocardial infarction promotes cardiac repair by enhanced neovascularization and cell survival.
    Zaruba MM; Huber BC; Brunner S; Deindl E; David R; Fischer R; Assmann G; Herbach N; Grundmann S; Wanke R; Mueller-Hoecker J; Franz WM
    Cardiovasc Res; 2008 Mar; 77(4):722-31. PubMed ID: 18055578
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Transplanted human umbilical cord blood mononuclear cells improve left ventricular function through angiogenesis in myocardial infarction.
    Hu CH; Wu GF; Wang XQ; Yang YH; Du ZM; He XH; Xiang P
    Chin Med J (Engl); 2006 Sep; 119(18):1499-506. PubMed ID: 16996002
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Does mobilisation of CD34+ stem cells along with VEGF, angiogenin, IL-6, IL-8, and hsCRP levels allow predicting the direction of left ventricular ejection fraction and wall motion score index changes in patients with myocardial infarction?
    Grąbczewska Z; Dębski R; Góralczyk K; Świątkiewicz I; Kubica J
    Kardiol Pol; 2013; 71(5):464-71. PubMed ID: 23788086
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Treatment with hESC-Derived Myocardial Precursors Improves Cardiac Function after a Myocardial Infarction.
    Ye J; Gaur M; Zhang Y; Sievers RE; Woods BJ; Aurigui J; Bernstein HS; Yeghiazarians Y
    PLoS One; 2015; 10(7):e0131123. PubMed ID: 26230835
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Long-term benefit of intracardiac delivery of autologous granulocyte-colony-stimulating factor-mobilized blood CD34+ cells containing cardiac progenitors on regional heart structure and function after myocardial infarct.
    Pasquet S; Sovalat H; Hénon P; Bischoff N; Arkam Y; Ojeda-Uribe M; Bouar Rl; Rimelen V; Brink I; Dallemand R; Monassier JP
    Cytotherapy; 2009; 11(8):1002-15. PubMed ID: 19929464
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Human cord blood cells induce angiogenesis following myocardial infarction in NOD/scid-mice.
    Ma N; Stamm C; Kaminski A; Li W; Kleine HD; Müller-Hilke B; Zhang L; Ladilov Y; Egger D; Steinhoff G
    Cardiovasc Res; 2005 Apr; 66(1):45-54. PubMed ID: 15769447
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hepatocyte growth factor prevents ventricular remodeling and dysfunction in mice via Akt pathway and angiogenesis.
    Wang Y; Ahmad N; Wani MA; Ashraf M
    J Mol Cell Cardiol; 2004 Nov; 37(5):1041-52. PubMed ID: 15522281
    [TBL] [Abstract][Full Text] [Related]  

  • 13. 18F-FDG PET-Based Imaging of Myocardial Inflammation Predicts a Functional Outcome Following Transplantation of mESC-Derived Cardiac Induced Cells in a Mouse Model of Myocardial Infarction.
    Vasudevan P; Gaebel R; Doering P; Mueller P; Lemcke H; Stenzel J; Lindner T; Kurth J; Steinhoff G; Vollmar B; Krause BJ; Ince H; David R; Lang CI
    Cells; 2019 Dec; 8(12):. PubMed ID: 31835854
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Heart infarct in NOD-SCID mice: therapeutic vasculogenesis by transplantation of human CD34+ cells and low dose CD34+KDR+ cells.
    Botta R; Gao E; Stassi G; Bonci D; Pelosi E; Zwas D; Patti M; Colonna L; Baiocchi M; Coppola S; Ma X; Condorelli G; Peschle C
    FASEB J; 2004 Sep; 18(12):1392-4. PubMed ID: 15231728
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Combination of CD34-positive cell subsets with infarcted myocardium-like matrix stiffness: a potential solution to cell-based cardiac repair.
    Zhang S; Ma X; Yao K; Zhu H; Huang Z; Shen L; Qian J; Zou Y; Sun A; Ge J
    J Cell Mol Med; 2014 Jun; 18(6):1236-8. PubMed ID: 24945435
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Transdifferentiation of human peripheral blood CD34+-enriched cell population into cardiomyocytes, endothelial cells, and smooth muscle cells in vivo.
    Yeh ET; Zhang S; Wu HD; Körbling M; Willerson JT; Estrov Z
    Circulation; 2003 Oct; 108(17):2070-3. PubMed ID: 14568894
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Functional and bioenergetic modulations in the infarct border zone following autologous mesenchymal stem cell transplantation.
    Feygin J; Mansoor A; Eckman P; Swingen C; Zhang J
    Am J Physiol Heart Circ Physiol; 2007 Sep; 293(3):H1772-80. PubMed ID: 17573463
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Repair of infarcted myocardium mediated by transplanted bone marrow-derived CD34+ stem cells in a nonhuman primate model.
    Yoshioka T; Ageyama N; Shibata H; Yasu T; Misawa Y; Takeuchi K; Matsui K; Yamamoto K; Terao K; Shimada K; Ikeda U; Ozawa K; Hanazono Y
    Stem Cells; 2005 Mar; 23(3):355-64. PubMed ID: 15749930
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Direct evaluation of myocardial viability and stem cell engraftment demonstrates salvage of the injured myocardium.
    Kim PJ; Mahmoudi M; Ge X; Matsuura Y; Toma I; Metzler S; Kooreman NG; Ramunas J; Holbrook C; McConnell MV; Blau H; Harnish P; Rulifson E; Yang PC
    Circ Res; 2015 Mar; 116(7):e40-50. PubMed ID: 25654979
    [TBL] [Abstract][Full Text] [Related]  

  • 20. CCR3- and CXCR4-mediated interactions regulate migration of CD34+ human bone marrow progenitors to ischemic myocardium and subsequent tissue repair.
    Bonaros N; Sondermeijer H; Schuster M; Rauf R; Wang SF; Seki T; Skerrett D; Itescu S; Kocher AA
    J Thorac Cardiovasc Surg; 2008 Oct; 136(4):1044-53. PubMed ID: 18954648
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.